As a solely dedicated European Metformin producer, we are a well positioned supplier to leading international pharmaceutical companies. Our strategy 2021-2025 is to significantly expand together with both current and new customers.
With long pharmaceutical industry experience, we have built significant capacity and expertise as an API provider. Vistin Pharma today produce about 10% of the world’s demand for Metformin HCl API, and have initiated a project to double the manufacturing capacity in 2022. Vistin Pharma has highly qualified employees and a dedicated manufacturing facility in Kragerø, Norway. The facility is certified according to current Good Manufacturing Practice (cGMP) and successfully inspected by the US Food and Drug Administration (FDA). Headquarter is located in Oslo, Norway.